HWGB Biotech aims to provide a comprehensive range of big health products and solutions that adopts a preventive measure readily available to give a peace of mind of many around the world.
Backed by a panel of experienced consultants with relevant experience in the healthcare and technology industry in regards to matters involving healthcare and biotechnology.
Ho Wah Genting Berhad (Bursa stock code:9601), through its wholly-owned subsidiary HWGB Biotech Sdn Bhd signed a joint venture agreement with US-based E-MO Biology Inc. (“EBI”) for the research and development of vaccines, immunological treatment, and diagnostic product development in relation to the COVID-19 virus, followed by the Memorandum of Agreement signed on 06 August 2020.
OJA Rapid diagnostic test kits (RTK) serves as an effective tool to help healthcare teams identify infected individuals and isolate outbreaks. It detects the presence of viral proteins (Antigens) expressed by the COVID-19 virus in a sample from the respiratory tract of a parson.
Ho Wah Genting Berhad (“HWGB” or the “Company”) (Bursa Stock Code:9601) is pleased to announce that the nucleic acid test kits manufactured by Wuhan Easydiagnosis Biomedicine Co Ltd (“Wuhan Easydiagnosis”) and authorised for distribution in Malaysia has passed with 100% accuracy an evaluation by the Ministry of Health’s (“MOH”) National Public Health Laboratory (“NPHL”).
D’VIRIA Nano CD disinfectant is a revolutionary,advanced delivery system to generate a highly pure aqueous chlorine dioxide solution. D’VIRIA Nano CD disinfectant does not contain any chlorine compounds.D’VIRIA Nano CD disinfectant has removed all known drawbacks, side-effects and by-products known from chlorine dioxide.
HWGB BIOTECH SDN BHD (Formerly known as HWG Consortium Sdn Bhd) [Company Number: 201201022032 (1006524-T)]
2020 HWGB Biotech. All rights Reserved.